表紙
市場調査レポート

膀胱癌治療薬の中国市場

Bladder Cancer Treatment Drugs Markets in China

発行 Asia Market Information & Development 商品コード 100203
出版日 ページ情報 英文 235 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
膀胱癌治療薬の中国市場 Bladder Cancer Treatment Drugs Markets in China
出版日: 2016年03月10日 ページ情報: 英文 235 Pages
概要

過去10年、中国における膀胱癌の治療薬に対する需要は急速に拡大しています。今後5年間においても生産、需要ともに増加しつづける見込みです。

当レポートでは、中国の経済動向、投資環境、産業の発展と需給動向とともに、マーケティングチャネルや主な業界参入企業を紹介しながら、長期的予測を交え、概略以下の構成でお届けします。

第1章 イントロダクション

  • 本調査書の範囲と調査方法
  • エグゼクティブサマリー

第2章 ビジネス環境

  • 経済見通し
  • 金融および税金の規制

第3章 膀胱癌治療薬の業界評価

  • 業界構造
  • 市場規模
  • 市場成長促進因子
  • 販売量
  • 主なメーカーの設備拠点
  • 主なメーカーの販売量および市場シェア
  • 人件費
  • 潜在的な参入企業
  • 主な流通業者
  • 主な海外資本
  • 技術発展

第4章 膀胱癌治療薬の生産と需要

  • 膀胱癌の概要
  • 膀胱癌治療薬市場の概要
  • 膀胱癌治療薬市場の概要:クラス別
  • 膀胱癌治療薬の輸出入:クラス別
  • 市場概要:有効成分別
  • 市場概要:メーカー別
  • 価格動向

第5章 市場見通し

  • 市場見通し
  • 政府の規制
  • 医療保険業界概要
    • 消費者支出動向
    • 人口統計動向
    • 医療業界動向
    • 病院および病床
    • 医師と医師の訪問

第6章 マーケティング戦略

  • 中国市場参入の概要
    • 中国の流通システム
    • 膀胱癌治療薬流通チャネル
    • 運輸および輸送インフラ
    • 通信
  • 中国市場参入
    • 技術供与
    • フランチャイズ
    • Eコマース
    • 貿易会社および現地代理店
    • 駐在員事務所および中国子会社
    • 完全外資企業

第7章 膀胱癌治療薬メーカーのディレクトリー

  • メーカープロファイル

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: 830

China's demand for Bladder Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2005, 2010 and 2015) and long-term forecasts through 2020 and 2025 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Bladder Cancer Treatment Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Bladder Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Producers' Sales Volume and Market Share
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development

IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Bladder Cancer Overview
  • Bladder Cancer Treatment Drugs Market Overview
  • Bladder Cancer Treatment Drugs Market Overview by Classification
  • Intraluminal Perfusion Agents
  • Unilateral Chemotherapy Drug
  • First-line Chemotherapy Drug
  • Immunomodulator
  • Other Drugs
  • Bladder Cancer Treatment Drugs Import and Export by Classification
  • Bladder Cancer Treatment Drugs Import
  • Import of Unilateral Chemotherapy Drug
  • Import of First-Line Chemotherapy Drug
  • Import of Intraluminal Perfusion Agents
  • Import of Immunomodulator
  • Import of Other Drugs
  • Bladder Cancer Treatment Drugs Export
  • Export of Unilateral Chemotherapy Drug
  • Export of First-Line Chemotherapy Drug
  • Export of Intraluminal Perfusion Agents
  • Export of Immunomodulator
  • Export of Other Drugs
  • Market Overview by Drug's Active Principle
  • Market Overview by Producers
  • Pricing Trend

V. BLADDER CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Bladder Cancer Treatment Drugs Markets Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKETING STRATEGIES

  • Distribution System in China
  • China's Distribution System
  • Bladder Cancer Treatment Drugs Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprise

VII. BLADDER CANCER TREATMENT DRUGS PRODUCER DIRECTORY

  • Profiles of Bladder Cancer Treatment Drugs Producers

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Top 14 Bladder Cancer Treatment Drugs Sales Volume and Market Share
  • Bladder Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Location
  • Major Bladder Cancer Treatment Drugs Producer Sales Volume and Their Market Share
  • Major Foreign Investment in China

IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Bladder Cancer Treatment Drugs Import by Country
  • Bladder Cancer Treatment Drugs Export by Country
  • Bladder Cancer Treatment Drugs Sales Volume by Drugs Classification
  • Bladder Cancer Treatment Drugs Import by Drugs Classification
  • Bladder Cancer Treatment Drugs Export by Drugs Classification
  • Top 14 Bladder Cancer Treatment Drugs Medication Value and Their Market Share
  • Top 14 Bladder Cancer Treatment Drugs Sales Volume and Their Market Share
  • Bladder Cancer Treatment Drugs Major Producer, Sales Volume, and Market Share

V. BLADDER CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • Bladder Cancer Treatment Drugs Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Industrial Output by Ownership
  • China's Imports and Exports

III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Bladder Cancer Treatment Drugs Sales Volume
  • Bladder Cancer Treatment Drugs Sales Volume by Drugs Classification
  • Top 14 Bladder Cancer Treatment Drugs Market Share

IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Bladder Cancer Treatment Drugs Sales Volume
  • Bladder Cancer Treatment Drugs Import
  • Bladder Cancer Treatment Drugs Import by Country
  • Bladder Cancer Treatment Drugs Export
  • Bladder Cancer Treatment Drugs Export by Country
  • Bladder Cancer Treatment Drugs Sales Volume by Classification
  • Intraluminal Perfusion Agents Sales Volume and Market Share
  • Unilateral Chemotherapy Drug Sales Volume and Market Share
  • First-Line Chemotherapy Drug Sales Volume and Market Share
  • Immunomodulator Sales Volume and Market Share
  • Other Drugs Sales Volume and Market Share
  • Bladder Cancer Treatment Drugs Import by Classification
  • Unilateral Chemotherapy Drug Import and Market Share
  • First-Line Chemotherapy Drug Import and Market Share
  • Intraluminal Perfusion Agents Import and Market Share
  • Immunomodulator Import and Market Share
  • Other Drugs Import and Market Share
  • Bladder Cancer Treatment Drugs Export by Drugs Classification
  • Unilateral Chemotherapy Drug Export and Market Share
  • First-Line Chemotherapy Drug Export and Market Share
  • Intraluminal Perfusion Agents Export and Market Share
  • Immunomodulator Export and Market Share

VI. MARKETING STRATEGIES

  • China's Distribution Channel
Back to Top